NASDAQ:FSLR

First Solar (NASDAQ:FSLR) Stock Analysis: Analyst Upgrades and Legal Challenges

Font: Financial Modeling Prep  • Jul 06, 2026

Market Chart
  • Analyst Optimism: Deutsche Bank and Wells Fargo have issued "Buy" and "Overweight" ratings, respectively, for First Solar, setting new price targets that suggest significant upside potential.
  • Market Position & Catalysts: As a leading U.S. manufacturer of thin-film solar modules, First Solar stands to benefit from potential tariffs on imported polysilicon, creating an "asymmetric upside."
  • Legal Hurdles: Despite positive analyst sentiment, the company faces a securities fraud lawsuit related to past guidance reductions and margin compression.

First Solar (NASDAQ:FSLR) is a major American company that designs and manufactures solar panels. It is a key player in the renewable energy sector, competing with other solar companies such as SolarEdge Technologies (NASDAQ:SEDG), Canadian Solar (NASDAQ:CSIQ), and Enphase Energy (NASDAQ:ENPH). First Solar focuses on thin-film solar modules, which sets it apart from many competitors who use crystalline silicon technology.

On July 6, 2026, an analyst from Deutsche Bank upgraded First Solar to a Buy rating from a Hold. As highlighted by TheFly, the firm also set a new price target of $272.00 for the stock. At the time, the stock was trading at $233.06, which suggests a potential upside of about 16.71% if it reaches the new target.

This positive outlook is shared by other analysts. A bullish note from Wells Fargo lifted its price target on First Solar to $320.00 from $255.00, while maintaining an Overweight rating. An Overweight rating means the analyst believes the stock will perform better than the overall market. This news helped push the shares up 5% to $236.52.

The optimism from Wells Fargo is partly due to a U.S. Department of Commerce investigation into imported polysilicon. This investigation could result in tariffs, or taxes, on imported materials. Such a move could benefit U.S.-based manufacturers like First Solar, creating what the analyst called a potential "asymmetric upside," meaning the potential for gain is greater than the potential for loss.

Despite the positive analyst ratings, the company faces legal challenges. Glancy Prongay Wolke & Rotter LLP announced a deadline for a securities fraud lawsuit against First Solar, as highlighted by GlobeNewswire. The lawsuit relates to a period where the company reportedly lowered its guidance, faced significant order cancellations, and experienced margin compression, which means its profitability on sales decreased.

Market Overview
ADGM
Adagio Medical Holdings, Inc.
$0.80
73.91%
TNMG
TNL Mediagene
$0.48
33.06%
ENSC
Ensysce Biosciences, Inc.
$0.38
37.17%
PLTR
Palantir Technologies Inc.
$162.66
29.45%
SXTC
China SXT Pharmaceuticals, Inc.
$0.12
60.08%
NVDA
NVIDIA Corporation
$211.94
2.56%
QNME
Lakeside Holding Limited
$0.69
-37.59%
AMIX
Autonomix Medical, Inc.
$19.50
434.25%
INTC
Intel Corp.
$100.86
10.84%
VTGN
VistaGen Therapeutics, Inc.
$0.30
22.45%